Despite a preliminary theory that health insurers could potentially hold too much buyer power, resulting in a loss of quality of consulting and preventative care for consumers, the Competition Commission has expressed support of health insurers in its most recent update of a widespread probe into the UK’s private healthcare sector. A common complaint, according to reports, often involves Bupa, one of the UK’s largest private medical insurers; the CC has received complaints that the insurer’s fee schedule reduces consultation quality and hinders innovation. The Commission has said it has “not seen evidence” of these claims, however. While its update did not come down hard on insurers, the Commission did suggest that there may be cause for concern within the private hospital operators’ sector.
Featured News
Antitrust Case Against Live Nation Moves Toward Jury Trial
Feb 19, 2026 by
CPI
State Attorneys General Signal They Will Continue Antitrust Fight Against Live Nation if DOJ Settles
Feb 19, 2026 by
CPI
French Antitrust Raid Targets Passenger Transport Sector
Feb 18, 2026 by
CPI
FTC Moves to Bring Back Rules To Make It Easier for Consumers to Cancel Subscriptions
Feb 18, 2026 by
CPI
California Lawmaker Backs Sweeping Antitrust Overhaul
Feb 18, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Hub-&-Spoke Conspiracies
Jan 26, 2026 by
CPI
A Data Analytics Company as the Hub in a Hub-and-Spoke Cartel
Jan 26, 2026 by
Joseph Harrington
Hub and Spoke Cartels
Jan 26, 2026 by
Patrick Van Cayseele
Hub-and-Spoke Collusion or Vertical Exclusion? Identifying the Rim in Hub-and-Spoke Conspiracies
Jan 26, 2026 by
Rosa Abrantes-Metz, Pedro Gonzaga, Laura Ildefonso & Albert Metz
The Algorithmic Middleman in a Hub-and-Spoke Conspiracy: Divergent Court Decisions and the Expanding Patchwork of State and Local Regulations
Jan 26, 2026 by
Bradley C. Weber